Methods And Compositions For Prediction Of Therapeutic Efficacy Of Cancer Treatments And Cancer Prognosis
Pharmaceutical Composition For Oral AdministrationĪpp 20210340549 - MARUI Takanori et al.Ĭomplex Having Anti-human Muc1 Antibody Fab Fragment, Peptide Linker And/or Ligandįatty Acid Derivative Labeled With Positron-emitting RadionuclideĪpp 20210338845 - Murakami Yoshihiro et al. Method For Treating Muscular Dystrophy By Targeting Utrophin Gene Pharmaceutical Composition Containing Tagged Site-antihuman Antibody Fab Fragment ComplexĪpp 20210355233 - Suemitsu Jumpei et al. Method for producing renal progenitor cells METHOD FOR TREATING CANCER USING ARTIFICIAL ADJUVANT CELL (aAVC)Īpp 20220016239 - OHSUMI Keisuke et al. Pharmaceutical Composition Comprising Anti-human Tslp Receptor Antibody March 22, 2Īnti-human NGF antibody Fab fragment and methods for treating postoperative pain related to NGF Method For Producing Nanoparticle Having Metal Particle Which Contains Iron Oxide To Which One Or More Hydrophilic Ligands Are Coordination BondedĪpp 20220089455 - KIKUCHI Takashi et al. April 26, 2Ĭonjugate Comprising Ligand, Spacer, Peptide Linker, And BiomoleculeĪpp 20220105194 - Akaiwa Michinori et al.Ĭonjugate Comprising Ligand And Ceacam5 Antibody Fab FragmentĪpp 20220096653 - Akaiwa Michinori et al.Ĭell culturing method using nucleic acid-containing medium
Exercise Management System, Server System, Terminal Device, And Exercise Management MethodĪpp 20220143464 - NISHIMOTO Yasuhiro et al.
0 kommentar(er)
